• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 6- Competition in the Marketplace

Article

Dr Fendrick asked panelists what they think about the idea of centers of excellence for specific cancers and an evidence-based steerage.

Dr Fendrick asked panelists what they think about the idea of centers of excellence for specific cancers and an evidence-based steerage. “There may be a value in having a centralized guidance of treatments adapted to a particular patient,” said Dr Ribas. Dr Ribas also discussed the effect future agents being developed for the treatment of melanoma will have on the market. He says prices will be adapted to the benefit due to more competition in the marketplace.

“Perhaps there is some relief on the horizon in terms of pricing because of competition,” said Dr Weber. “Classic essence of capitalism.”

Related Videos
James Chambers, PhD
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Screenshot of an interview with Ruben Mesa, MD
Screenshot of Adam Colborn, JD during an interview
Ruben Mesa, MD
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Screenshot of Susan Wescott, RPh, MBA
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Screenshot of Stephanie Hsia, PharmD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.